Drug wholesale prices up over 7% in 2007

Share this article:

Pharmaceutical manufacturers increased wholesale prices for the 50 top-selling branded medications by an average of 7.82% in 2007, after increases of 6.73% and 6.22% in the previous two years, according to data from marketing research firm Delta Marketing Dynamics.

The most recent increase is almost double the overall U.S. economy's 4.1% annual inflation rate last year, a report in today's Wall Street Journal said.

GlaxoSmithKline raised the price of its antidepressant Wellbutrin XL by 44.5% from 2005 to 2007. Sanofi Aventis raised the price of its sleep drug Ambien 70.1%.

Shire upped the price of its attention-deficit disorder treatement, Adderall XR, by 33.5%.

Pfizer's cholesterol-fighting Lipitor -- the world's top-selling Rx drug with $13 billion in sales, rose 16%.

Share this article:

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.